{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ziprasidone+%28Geodon%29", "query": { "intervention": "ziprasidone (Geodon)" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 81, "total_pages": 9, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ziprasidone+%28Geodon%29&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-16T16:26:17.503Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00806234", "title": "Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Psychotic Disorders" ], "interventions": [ { "name": "Aripiprazole or Perphenazine", "type": "DRUG" }, { "name": "Metformin", "type": "DRUG" }, { "name": "Olanzapine, quetiapine, risperidone, ziprasidone, aripiprazole, asenapine, iloperidone, lurasidone, paliperidone, or olanzapine/fluoxetine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "8 Years", "maximum_age": "19 Years", "sex": "ALL", "summary": "8 Years to 19 Years" }, "enrollment_count": 127, "start_date": "2009-01", "completion_date": "2014-03", "has_results": true, "last_update_posted_date": "2017-04-25", "last_synced_at": "2026-09-16T16:26:17.503Z", "location_count": 4, "location_summary": "Baltimore, Maryland • Glen Oaks, New York • Chapel Hill, North Carolina", "locations": [ { "city": "Baltimore", "state": "Maryland" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Glen Oaks", "state": "New York" }, { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00806234" }, { "nct_id": "NCT04002700", "title": "A Study to Assess Stroke Risk Among Users of Typical Versus Atypical Antipsychotics Stratified by Broad Age Group", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Stroke" ], "interventions": [ { "name": "Haloperidol", "type": "DRUG" }, { "name": "Typical Antipsychotics", "type": "DRUG" }, { "name": "Atypical Antipsychotics", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1234412, "start_date": "2019-05-06", "completion_date": "2019-05-31", "has_results": false, "last_update_posted_date": "2025-06-25", "last_synced_at": "2026-09-16T16:26:17.503Z", "location_count": 1, "location_summary": "Titusville, New Jersey", "locations": [ { "city": "Titusville", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT04002700" }, { "nct_id": "NCT00014001", "title": "CATIE- Schizophrenia Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "perphenazine", "type": "DRUG" }, { "name": "olanzapine", "type": "DRUG" }, { "name": "quetiapine", "type": "DRUG" }, { "name": "risperidone", "type": "DRUG" }, { "name": "ziprasidone", "type": "DRUG" }, { "name": "clozapine", "type": "DRUG" }, { "name": "fluphenazine decanoate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Mental Health (NIMH)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 1600, "start_date": "2000-12", "completion_date": "2004-12", "has_results": false, "last_update_posted_date": "2015-06-17", "last_synced_at": "2026-09-16T16:26:17.503Z", "location_count": 54, "location_summary": "Chula Vista, California • Los Angeles, California • Orange, California + 45 more", "locations": [ { "city": "Chula Vista", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00014001" }, { "nct_id": "NCT02600741", "title": "Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Caregiver psycho-education and skills training", "type": "OTHER" }, { "name": "Caregiver support available at the study site", "type": "OTHER" }, { "name": "Paliperidone palmitate", "type": "DRUG" }, { "name": "Chlorpromazine", "type": "DRUG" }, { "name": "Droperidol", "type": "DRUG" }, { "name": "Fluphenazine", "type": "DRUG" }, { "name": "Haloperidol", "type": "DRUG" }, { "name": "Loxapine", "type": "DRUG" }, { "name": "Perphenazine", "type": "DRUG" }, { "name": "Pimozide", "type": "DRUG" }, { "name": "Prochlorperazine", "type": "DRUG" }, { "name": "Thiothixene", "type": "DRUG" }, { "name": "Thioridazine", "type": "DRUG" }, { "name": "Trifluoperazine", "type": "DRUG" }, { "name": "Aripiprazole", "type": "DRUG" }, { "name": "Asenapine", "type": "DRUG" }, { "name": "Clozapine", "type": "DRUG" }, { "name": "Iloperidone", "type": "DRUG" }, { "name": "Olanzapine", "type": "DRUG" }, { "name": "Paliperidone", "type": "DRUG" }, { "name": "Quetiapine", "type": "DRUG" }, { "name": "Risperidone", "type": "DRUG" }, { "name": "Ziprasidone", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "Janssen Scientific Affairs, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 296, "start_date": "2015-07-24", "completion_date": "2018-07-05", "has_results": false, "last_update_posted_date": "2019-01-23", "last_synced_at": "2026-09-16T16:26:17.503Z", "location_count": 34, "location_summary": "Bullhead City, Arizona • Oceanside, California • Denver, Colorado + 31 more", "locations": [ { "city": "Bullhead City", "state": "Arizona" }, { "city": "Oceanside", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Farmington", "state": "Connecticut" }, { "city": "Lauderdale Lakes", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02600741" }, { "nct_id": "NCT00280566", "title": "Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolar I Disorder (Manic or Mixed)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bipolar Mania", "Bipolar Disorder" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Ziprasidone Oral Capsule", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 584, "start_date": "2005-12", "completion_date": "2008-05", "has_results": true, "last_update_posted_date": "2021-03-25", "last_synced_at": "2026-09-16T16:26:17.503Z", "location_count": 73, "location_summary": "Birmingham, Alabama • Scottsdale, Arizona • Little Rock, Arkansas + 59 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00280566" }, { "nct_id": "NCT01172652", "title": "Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Bipolar Disorder", "Panic Disorder", "Generalized Anxiety Disorder" ], "interventions": [ { "name": "Ziprasidone", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "VA Palo Alto Health Care System", "sponsor_class": "FED", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 49, "start_date": "2010-04", "completion_date": "2011-10", "has_results": true, "last_update_posted_date": "2025-04-08", "last_synced_at": "2026-09-16T16:26:17.503Z", "location_count": 3, "location_summary": "Palo Alto, California • Tampa, Florida • Mason, Ohio", "locations": [ { "city": "Palo Alto", "state": "California" }, { "city": "Tampa", "state": "Florida" }, { "city": "Mason", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01172652" }, { "nct_id": "NCT03837860", "title": "Reducing the Abuse of Opioids in Drug Users", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Opioid Abuse, Unspecified", "Opioid Dependence" ], "interventions": [ { "name": "Oxycodone/Placebo", "type": "DRUG" }, { "name": "Oxycodone/Risperidone", "type": "DRUG" }, { "name": "Oxycodone/Ziprasidone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The University of Texas Health Science Center at San Antonio", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "21 Years to 65 Years" }, "enrollment_count": 3, "start_date": "2019-04-01", "completion_date": "2022-01-21", "has_results": false, "last_update_posted_date": "2022-02-15", "last_synced_at": "2026-09-16T16:26:17.503Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03837860" }, { "nct_id": "NCT00141271", "title": "A Six-Week Study Evaluating The Efficacy And Safety Of Geodon In Patients With A Diagnosis Of Bipolar I Depression", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bipolar Disorder" ], "interventions": [ { "name": "Geodon (Ziprasidone)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 536, "start_date": "2005-07", "completion_date": "2008-02", "has_results": true, "last_update_posted_date": "2021-03-25", "last_synced_at": "2026-09-16T16:26:17.503Z", "location_count": 72, "location_summary": "Birmingham, Alabama • Dana Point, California • La Mesa, California + 60 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Dana Point", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "Laguna Hills", "state": "California" }, { "city": "Oceanside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00141271" }, { "nct_id": "NCT06482554", "title": "Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Apathy", "Schizophrenia", "Schizophrenia; Psychosis" ], "interventions": [ { "name": "Lumateperone 42 mg", "type": "DRUG" }, { "name": "Risperidone 2 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Louisiana State University Health Sciences Center Shreveport", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 80, "start_date": "2024-06", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2024-07-01", "last_synced_at": "2026-09-16T16:26:17.503Z", "location_count": 1, "location_summary": "Shreveport, Louisiana", "locations": [ { "city": "Shreveport", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT06482554" }, { "nct_id": "NCT01006551", "title": "Ziprasidone in Early Onset Schizophrenia Spectrum Disorders", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Ziprasidone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "19 Years", "sex": "ALL", "summary": "6 Years to 19 Years" }, "enrollment_count": 40, "start_date": "2002-12", "completion_date": "2006-02", "has_results": false, "last_update_posted_date": "2024-08-15", "last_synced_at": "2026-09-16T16:26:17.503Z", "location_count": 4, "location_summary": "Medford, Massachusetts • Chapel Hill, North Carolina • Cleveland, Ohio + 1 more", "locations": [ { "city": "Medford", "state": "Massachusetts" }, { "city": "Chapel Hill", "state": "North Carolina" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT01006551" } ] }